Nostos Genomics is on a mission to improve the lives of the 400 million people around the world who have a genetic disease.
To diagnose a genetic disease, PhD-trained analysts employed by genetic testing labs currently spend on average 2 days investigating a single patient’s genetic mutations. Because of this, hundreds of labs around the world have limited throughput, profit margins and diagnostic yield, while struggling to capture the sky-rocketing demand for genetic tests.
Nostos Genomics automated this process with a patent-pending technology combining explainable AI and synthetic biology and built the first cloud platform for genetic mutation analysis that takes less than 2 minutes until diagnosis while being fully interpretable by humans. Our platform is validated with >5K patient cases, contains >100M mutations and is already used by 4 genetic testing centers as part of our early access program, with one of the largest in Europe among them
